Skip to main content
in case you missed it

Executive chairman of Loblaw Companies Limited Galen G. Weston and Chair of the Board of Directors of Shoppers Drug Mart Holger Kluge (R) speak during a news conference in Toronto, July 15, 2013.MARK BLINCH/Reuters

Loblaw Cos. Ltd. struck a $12.4-billion deal for Shoppers Drug Mart Corp. Monday. Here is The Globe's complete coverage of the major acquisition:


Loblaw's bulk buy: $12.4-billion deal for Shoppers creates a colossus of retail

Galen G. Weston's plan to grow his family's legacy

Loblaw and Shoppers by the numbers

Loblaw, Empire deals pushing up neighbours' prices

What shoppers, analysts think about Loblaw deal


Loblaw's big bet on thinking small

Why would Shoppers agree not to shop for a better offer?

Loblaw looks to a new generation of shoppers

Not much for the Loblaw REIT in Shoppers deal

What does the Loblaw-Shoppers Drug Mart marriage mean for consumers?

How the Loblaw-Shoppers deal will affect your ETFs

Takeover lesson: Shoppers is no BlackBerry

For the bankers in the grocery wars, solo lending is key

Banks' willingness for risk made Loblaw deal possible

Shoppers purchase a strong play for Loblaw


Shoppers customers ask: What happens to my Optimum points?

Can Loblaw make the Shoppers deal work?

What is Loblaw buying?

Loblaw's Weston says Shoppers deal happened quickly

Is Loblaw's Shoppers deal the right prescription for drug and food retail?

Report an error

Editorial code of conduct

Tickers mentioned in this story